HUM vs ZBIO · P/E 39, rev $129.66B vs rev $5.0M
Humana Inc (HUM) versus Zenas BioPharma, Inc. Common Stock (ZBIO) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Zenas BioPharma, Inc. Common Stock (ZBIO) is a biotechnology company listed on US.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported ZBIO revenue for 2024-12-31 was $5.0M. Net income was -$157.0M. Revenue was down 90.0% from 2023-12-31 to 2024-12-31. ZBIO currently screens at market cap $798.0M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. ZBIO currently screens at market cap $798.0M.
Not investment advice. Open the HUM and ZBIO stock pages for the full models.
Not investment advice.